We came across a bullish thesis on Amgen Inc. (AMGN) on Disruptive analytics’ Substack by Magnus Ofstad. In this article we ...

Amgen Inc. closed $13.93 short of its 52-week high ($346.85), which the company reached on July 25th.

Shares of Amgen Inc. AMGN slumped 0.73% to $332.80 Tuesday, on what proved to be an all-around mixed trading session for the ...

Investigators compared outcomes between patients with stage II/III colon cancer given adjuvant aspirin and those given ...

Rory McIlroy has 17 DP World Tour wins. He's 18 holes from adding an 18th. McIlroy tied for low the round of the day on ...

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of ...

An academic partnership to improve diversity in clinical trials has drafted its first industry team members. | An academic ...

In a report released today, Michael Yee from Jefferies assigned a Buy rating to Amgen (AMGN – Research Report), with a price target of ...

False Claims Act suit alleging that medical practices engaged in a scheme to overbill Medicare for Amgen Inc. drugs is now dismissed, a New York federal district court said.

Matteo Manassero holds the halfway lead at Royal County Down; Rory McIlroy two back after a second-round 70 and Shane Lowry ...

In an interview with Targeted Oncology, Mark R. Litzow, MD, discussed the incorporation of Immunotherapy into upfront acute ...

Rasmus Hojgaard produced a remarkable finish to snatch a one-shot win at the Amgen Irish Open, as Rory McIlroy failed to ...